Key facts

Invented name
Xerava
Active Substance
eravacycline
Therapeutic area
Infectious diseases
Decision number
P/0255/2020
PIP number
EMEA-001555-PIP01-13-M04
Pharmaceutical form(s)
Powder for concentrate for solution for infusion
Condition(s) / indication(s)
Treatment of complicated intra-abdominal infection
Route(s) of administration
Intravenous use
Contact for public enquiries

PAION Deutschland GmbH

Tel. +49 241 4453 0
E-mail: reg_paion@paion.com

Decision type
PM: decision on the application for modification of an agreed PIP
Decision date

Decision

P/0255/2020 : EMA decision of 15 July 2020 on the acceptance of a modification of an agreed paediatric investigation plan for Eravacycline (Xerava) (EMEA-001555-PIP01-13-M04)

How useful do you find this page?